Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody
5
(4 Reviews)
|
(24 Publications)
Rabbit Polyclonal Eph receptor B1/NET phospho Y594 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 24 publications. Immunogen corresponding to Synthetic Peptide within Mouse Ephb2 phospho Y594 + Y596.
View Alternative Names
ELK, EPHT2, HEK6, NET, EPHB1, Ephrin type-B receptor 1, EPH tyrosine kinase 2, EPH-like kinase 6, Neuronally-expressed EPH-related tyrosine kinase, Tyrosine-protein kinase receptor EPH-2, EK6, hEK6
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (AB61791)
Immunofluorescence analysis of HuvEc cells, using ab61791 at 1/500-1/1000 dilution with (+) or without (-) immunising phosphopeptide.
- ICC/IF
AbReview41906****
Immunocytochemistry/ Immunofluorescence - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (AB61791)
ab61791 staining Eph receptor B1 + Eph receptor B2 (phospho Y594) in HeLa cells (overexpressing EphB2 and stimulated for 20 minutes with preclustered efnb1-Fc chimeric protein) by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 1% BSA for 30 minutes at 25°C. Samples were incubated with primary antibody (1/100 in PBS + 1% BSA + 0.1% Triton X-100) for 2 hour at 25°C. An Alexa Fluor® 488-conjugated donkey anti-rabbit IgG polyclonal (1/300) was used as the secondary antibody. Red - anti-EphB2 (goat), Grey - DAPI, Green - ab61791.
This image is courtesy of an Abreview submitted by Thomas Jungas
- WB
Unknown
Western blot - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (AB61791)
All lanes:
Western blot - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (ab61791) at 1/500 dilution
Lane 1:
Extracts from HepG2 cells
Lane 2:
Extracts from HepG2 cells with the immunising phosphopeptide
Predicted band size: 110 kDa
Observed band size: 110 kDa
false
- WB
AbReview41567****
Western blot - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (AB61791)
All cells were stimulated with preclustered ephrinb1-Fc chimeric protein.
All lanes:
Western blot - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (ab61791) at 1/1000 dilution
Lane 1:
HeLa whole cell lysate at 100000 Cells
Lane 2:
HeLa whole cell lysate - overexpressing EphB2 at 100000 Cells
Lane 3:
HeLa whole cell lysate - overexpressinf EphB2-kinase dead (K661R) at 100000 Cells
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG monoclonal at 1/5000 dilution
Predicted band size: 110 kDa
Observed band size: 110 kDa
true
Exposure time: 5min
This image is courtesy of an Abreview submitted by Thomas Jungas
- WB
CiteAb
Western blot - Anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody (AB61791)
Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) western blot using anti-Eph receptor B1 + Eph receptor B2 (phospho Y594 + Y596) antibody ab61791. Publication image and figure legend from Wu, Z., Ashlin, T. G., et al., 2019, Exp Cell Res, PubMed 31075258.
ab61791 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab61791 please see the product overview.
Activation of EphB2 by ephrinB1 and ephrinB1-6F. (A) : Cells expressing EphB2, ephrinB1 or ephrinB1-6F, or control HEK293 cells, were mixed in different combinations in a tube and centrifuged to force them into contact. The cells were lysed at the indicated time points, then subjected to Western blot analysis to detect EphB2, phospho-EphB2 and ephrinB1, and Gapdh as loading control. (B) : Quantitation of phospho-EphB2 detected, normalised to the amount of EphB2 protein. The low amount of endogenous ephrinBs in HEK293 cells elicit low level EphB2 phosphorylation. There is a similar time course of EphB2 phosphorylation after interaction with ephrinB1 or ephrinB1-6F cells, with a >30-fold increase by 5 min that progressively declines at 15 min and 30 min. (C-H) : immunostaining of co-cultures of EphB2/ephrinB1 (C–E) and EphB2/ephrinB1-6F cells (F-H) to detect p-EphB2 and a marker of intracellular vesicles, Rab11. EphB2 cells co-express GFP (green signal in C, F). Activation of EphB2 with ephrinB1 or ephrinB1-6F leads to translocation from the cell surface to intracellular vesicles. Scale bar, 10 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EphB1 and EphB2 are involved in processes such as neuronal development and angiogenesis. They participate in forming signaling complexes that guide cell sorting and boundary formation. These receptors interact with ephrin-B ligands initiating bidirectional signaling that influences cellular repulsion and adhesion. Their activities are essential for maintaining proper tissue architecture and directing axon pathfinding.
Pathways
EphB1 and EphB2 integrate into the Eph-ephrin signaling pathway and distinct Rho GTPase signaling pathways. These receptors activate intracellular signaling cascades that regulate cytoskeletal dynamics. They also interact with proteins like Src family kinases which modulate signal transduction processes necessary for cell migration and axonal guidance. This signaling contributes to key biological functions like tissue development and maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 8: PubMed37485875
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:980 PubMed36402751
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 38:110510 PubMed35294885
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinical science (London, England : 1979) 135:2127-2142 PubMed34462781
2021
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33627480
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pain 16:1744806920984079 PubMed33356837
2020
Applications
Unspecified application
Species
Unspecified reactive species
European journal of pain (London, England) 24:1968-1978 PubMed32841448
2020
Applications
Unspecified application
Species
Unspecified reactive species
BMC developmental biology 20:12 PubMed32404061
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 11:4123-4131 PubMed32368295
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 381:57-65 PubMed31075258
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com